Panagora Asset Management’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,362
Closed -$635K 1330
2023
Q1
$635K Sell
1,362
-341
-20% -$180K ﹤0.01% 1027
2022
Q4
$682K Sell
1,703
-8,962
-84% -$3.43M ﹤0.01% 1036
2022
Q3
$3.47M Buy
10,665
+4,160
+64% +$1.34M 0.02% 447
2022
Q2
$1.72M Buy
6,505
+5,396
+487% +$1.38M 0.01% 672
2022
Q1
$333K Buy
+1,109
New +$387K ﹤0.01% 1338
2020
Q3
Sell
-12
Closed -$12K 2713
2020
Q2
$12K Hold
12
﹤0.01% 2223
2020
Q1
$11K Hold
12
﹤0.01% 2124
2019
Q4
$13K Hold
12
﹤0.01% 2093
2019
Q3
$11K Sell
12
-2
-14% -$2.2K ﹤0.01% 2157
2019
Q2
$16K Hold
14
﹤0.01% 2322
2019
Q1
$19K Sell
14
-101
-88% -$137K ﹤0.01% 2271
2018
Q4
$133K Sell
115
-1,209
-91% -$1.36M ﹤0.01% 1741
2018
Q3
$2.01M Sell
1,324
-139
-10% -$214K 0.01% 837
2018
Q2
$2.29M Sell
1,463
-1,516
-51% -$1.98M 0.01% 821
2018
Q1
$3.44M Sell
2,979
-5,214
-64% -$6.87M 0.01% 668
2017
Q4
$9.71M Sell
8,193
-66
-0.8% -$82.8K 0.04% 395
2017
Q3
$11.1M Sell
8,259
-331
-4% -$349K 0.04% 382
2017
Q2
$6.94M Buy
8,590
+7,726
+894% +$5.38M 0.03% 490
2017
Q1
$533K Buy
864
+273
+46% +$166K ﹤0.01% 1364
2016
Q4
$316K Sell
591
-1,481
-71% -$739K ﹤0.01% 1605
2016
Q3
$1.07M Buy
2,072
+1,519
+275% +$716K 0.01% 1168
2016
Q2
$227K Sell
553
-9
-2% -$4.12K ﹤0.01% 1625
2016
Q1
$299K Buy
562
+151
+37% +$75.2K ﹤0.01% 1509
2015
Q4
$313K Sell
411
-67
-14% -$44.5K ﹤0.01% 1463
2015
Q3
$262K Buy
+478
New +$290K ﹤0.01% 1524

Other funds holding KYNB

Panagora Asset Management's KYNB Position: Q2 2023 in Review

Panagora Asset Management sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 1,362 shares — an estimated $635K sold.

Panagora Asset Management first reported a position in KYNB in Q3 2015 and held it in 25 quarters. The position peaked at $11.1M in Q3 2017. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • Panagora Asset Management reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • Panagora Asset Management sold 1,362 Kyntra Bio shares in Q2 2023, an estimated $635K.
  • Panagora Asset Management first reported a position in Kyntra Bio in Q3 2015 and held it in 25 quarters.
  • Panagora Asset Management's Kyntra Bio position peaked at $11.1M in Q3 2017.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Panagora Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.